<qa>  What is the clinical benefit of the study?This study would allow continued treatment of patients with partial forms of lipodystrophy who volunteered and completed treatment under the investigators ongoing protocol MB002-014 and who have derived significant clinical benefit as judged by an amelioration of their HbA1c, triglyceride levels, andor reduction in their baseline diabetes or lipid therapies that affect quality of life. 